View in browser

Issue 8 - Oct, 2016                                                                           

Sign me up for Catalyst Newsletters & Seminars               

In This Issue:

  • UCSF Catalyst News
  • Moving Towards the Clinic (Past Awardee Updates)
  • Catalyst Advisor Updates
  • Translational Research Funding Opportunities
  • Upcoming Events

Catalyst News:

The Catalyst Team Welcomes Two New Members: 


Roopa Ramamoorthi, PhD, Sr. Program Manager comes to us from BIO Ventures for Global Health, where she was the Associate Director of Partnering & Scientific Affairs. She also has experience in biological therapeutic product development at Bayer and in program and alliance management with pharmaceutical and academic partners. 

Yan Cao, PhD, Sr. Program Manager, comes to Catalyst from Invitae Corp, where she was the head of program management office.  Yan’s prior experiences include product and alliance management with Life Technologies and Affymetrix.  She is trained as a pharmacologist, with deep expertise in development of genomic technologies. 

More Team Updates: 

Congratulations to Cathy Tralau-Stewart, PhD, who is now an Adjunct Associate Professor of Bioengineering and Therapeutic Sciences in addition to her ongoing role as Associate Director, Catalyst.

Cammie Wilson, PhD, Catalyst Fellow 2015-16, conducted her post-doctoral research in Dr. Ethan Weiss's lab focused on understanding how growth hormone regulates lipid metabolism and excess storage of fat in the liver. She is now a consultant at The Boston Consulting Group in Philadelphia, working in the Healthcare sector with Biopharma & Biotechnology clients. 

CTSI, Home of Catalyst, Receives $85M Grant for 5 Years 

UC San Francisco’s Clinical and Translational Science Institute (CTSI), where the Catalyst program resides, was awarded $85M grant over five years from the National Institutes of Health (NIH).  This funding will enable CTSI to continue to provide training,  research support and other services and to launch new programs aimed at diversifying patients and advancing precision medicine. Read more

UC Center for Accelerated Innovation News:  

UC Center for Accelerated Innovation, a 5-campus technology development program, announced the new set of award winners.  In this round UCSF received  4 out of the 6 awards, and overall UCSF has obtained 10 of 24 awards given so far.   Congratulation to: 
Michael Conte, MD and Tejal Desai, PhD for their project, “Pro-resolving nanoparticles to improve vascular patency
Richard Fidler, II, PhD, CRNA and Xiao Hu, PhD for their project, “Data fusion and analytics to predict in hospital cardiopulmonary arrests and reduce alarm fatigue
Shuvo Roy, PhD and Benjamin Padilla, MD, for their project, “HEAL-High efficiency artificial lung
Dean Sheppard, MD and William DeGrado, PhD  for their project, “Inhibition of abnormal airway smooth muscle contraction by integrin inhibitors
Xiao Hu, PhD, Shuvo Roy, PhD and Michael Conte, MD, had previously won Catalyst awards for early development of their project ideas.   
New application cycle is open!  LOI due Nov 18th, pre-application due Dec 9th. More Info.

AstraZeneca/MedImmune to Strengthen Presence in CA With New South San Francisco Location:  

MedImmune, a partner to the Catalyst program, announced plans to consolidate its Bay area locations into a new cutting edge site in SSF.  We look forward to greater interactions with MedImmune and to increasing collaborations with UCSF researchers.  Read more
Moving Towards the Clinic: 
  • John Fahy, MD, a Catalyst awardee in Spring 2012 and winner of UC Center for Accelerated Innovation grant, secured a Translational Project Program grant from NHLBI to advance his development program for a novel inhaled mucolytic to a Phase I clinical study.
  • The technology of Bin Liu, PhD, Catalyst consultation awardee (fall 2014), on novel antibody-drug conjugates, was licensed by Fortis Therapeutics, an early stage immuno-oncology company.  Fortis raised $18M Series A funding and will focus on advanced prostate cancer indications.
Catalyst Advisor Updates:   See other Catalyst Advisors

Translational Research Funding Opportunities:

  • Nina Ireland Program for Lung Health (NIPLH) Innovative Grants Program: Proposals in clinical, translational, or bench research in any topic in Pulmonary medicine, especially those related to underserved & health disparities, locally & globally. $50k per yr for 1 or 2 yrs; due Oct 14th;
  • NCATS: Funding Opportunity for New Bench-to-Clinic Repurposing Initiative; LOI due Oct 14th
  • Michael J. Fox Foundation: Funds target advancement, therapeutic development & outcome measures for Parkinson’s diseases. Pre-proposal due Oct 19th
  • CARB-X: Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator- Est. to spur preclinical product development. LOI due 5pm EST Oct 31st;
  • Alex's Lemonade Stand Foundation: Awards of $125k annually for 2 yrs. ALSF seeks game changing proposals to substantially advance childhood cancer treatments and cures. LOI due Nov 1st, full app due Mar 6th;
  • UC CAI NHLBI Tech Grants: Awards up to $200k for development of drugs, devices (including wireless), diagnostics & tools that address heart, lung & blood diseases. LOI due Nov 18th; full application due by Dec 9th;
  • CIRM: California Institute for Regenerative Medicine (CIRM) supports stem cell based product development including stem cell based therapeutics & medical devices for therapy; Due Dec 15th;
  • Grants4LeadsFunding novel small-molecule leads that relate particularly to the fields of oncology, cardiology, hematology and gynecological therapies. Due Mar 31st; 
  • NIH/NINDS Office of Translational Research: Multiple translational opportunities for technology development in neurological diseases and stroke.  Explore opportunities

Upcoming Events:

  • Bay Area Biotechnology Symposium: What's New in Biotech? Mission Bay / Byers Auditorium, Oct 15th
  • Antibody Technology Research Center Symposium: Mission Bay Conference Center, Oct 17th
  • Developing Biologics for Phase I/II Trials: Manufacturing, Toxicology & Regulatory Challenges, by Anthony R. Welch (NCI): UCSF, Helen Diller Family Comprehensive Cancer Center, 1450 3rd St. HD-160, 12:00-1:00pm Oct 19th
  • Improve Your Pitch Deck with Data Visualization: Mission Bay QB3 Byers Hall Room 212, Oct 25th
  • UCSF Orthotic and Prosthetic Innovation and Technology Conference: 500 Parnassus Oct 28-29th
  • IDSA Medical Design Conference 2016: From Volume to Value / Mission Bay Conference Center, Nov 11-12th;  
  • Rare Disease Symposium, tentatively scheduled for Mar 3rd, 2017 / Byers Auditorium Mission Bay

UCSF Catalyst Awards Program
University of California, San Francisco (UCSF)
CTSI, Box 0558
550 16th Street (at corner of 4th St.)
6th Floor, San Francisco, CA 94158

Catalyst Awards Program | UCSF Profiles

Sign me up for Catalyst Newsletters & Seminars

UCSF Orthotics &Prosthetics Innovation & Tech Conference: SF
505 Parnassus 
IDSA Medical Design Conference: UCSF Mission Bay
Tranlsational Medicine & Bioengineering: SF
UC CAI NHLBI Tech Grants: LOI due
UC Wide-Drug Discovery Symposium: UCLA
UCSF technologies available for partnering 
Work with CDHI to fulfill a clinical need at UCSF
Support at Every Stage of a Device Startup Website
Contact our team
UCSF Profiles
Search, Discover, Network

UCSF Cores Search
Equipment & Services for Researchers

UCSF Open Proposals

Enabling Proposal & Team Development
CTSI Research Navigation Services
Get help finding research resources and information.
Help us support your research. Please cite our grant in all publications supported by CTSI, and comply with NIH Public Access Policy.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UCSF Catalyst Program Newsletter · UCSF CTSI · 550 16th St, MIssion Hall 6th Floor · San Francisco, CA 94158-0558 · USA